Pregled bibliografske jedinice broj: 1260390
Simultaneous Onset of Haematological Malignancy and COVID: An Epicovideha Survey
Simultaneous Onset of Haematological Malignancy and COVID: An Epicovideha Survey // Cancers, 14 (2022), 22; 5530, 16 doi:10.3390/cancers14225530 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1260390 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Simultaneous Onset of Haematological Malignancy and
COVID: An Epicovideha Survey
Autori
Cattaneo, Chiara ; Salmanton-García, Jon ; Marchesi, Francesco ; El- Ashwah, Shaimaa ; Itri, Federico ; Weinbergerová, Barbora ; Gomes Da Silva, Maria ; Dargenio, Michelina ; Dávila-Valls, Julio ; Martín- Pérez, Sonia ; Farina, Francesca ; Van Doesum, Jaap ; Valković, Toni ; Besson, Caroline ; Poulsen, Christian Bjørn ; López- García, Alberto ; Žák, Pavel ; Schönlein, Martin ; Piukovics, Klára ; Jakšić, Ozren ; Cabirta, Alba ; Ali, Natasha ; Sili, Uluhan ; Fracchiolla, Nicola ; Dragonetti, Giulia ; Adžić-Vukičević, Tatjana ; Marchetti, Monia ; Machado, Marina ; Glenthøj, Andreas ; Finizio, Olimpia ; Demirkan, Fatih ; Blennow, Ola ; Tisi, Maria Chiara ; Omrani, Ali S. ; Navrátil, Milan ; Ráčil, Zdeněk ; Novák, Jan ; Magliano, Gabriele ; Jiménez, Moraima ; Garcia- Vidal, Carolina ; Erben, Nurettin ; Del Principe, Maria Ilaria ; Buquicchio, Caterina ; Bergantim, Rui ; Batinić, Josip ; Al-Khabori, Murtadha ; Verga, Luisa ; Szotkowski, Tomáš ; Samarkos, Michail ; Ormazabal-Vélez, Irati ; Meers, Stef ; Maertens, Johan ; Pinczés, László Imre ; Hoenigl, Martin ; Drgoňa, Ľuboš ; Cuccaro, Annarosa ; Bilgin, Yavuz M. ; Aujayeb, Avinash ; Rahimli, Laman ; Gräfe, Stefanie ; Sciumè, Mariarita ; Mladenović, Miloš ; Çolak, Gökçe Melis ; Sacchi, Maria Vittoria ; Nordlander, Anna ; Berg Venemyr, Caroline ; Hanáková, Michaela ; García-Poutón, Nicole ; Emarah, Ziad ; Zambrotta, Giovanni Paolo Maria ; Nunes Rodrigues, Raquel ; Cordoba, Raul ; Méndez, Gustavo-Adolfo ; Biernat, Monika M. ; Cornely, Oliver A. ; Pagano, Livio
Izvornik
Cancers (2072-6694) 14
(2022), 22;
5530, 16
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
haematological malignancy onset ; COVID-19 ; treatment ; outcome ; prognostic factors
Sažetak
Background: The outcome of patients with simultaneous diagnosis of haematological malignancies (HM) and COVID-19 is unknown and there are no specific treatment guidelines. Methods: We describe the clinical features and outcome of a cohort of 450 patients with simultaneous diagnosis of HM and COVID- 19 registered in the EPICOVIDEHA registry between March 2020 to February 2022. Results: Acute leukaemia and lymphoma were the most frequent HM (35.8% and 35.1%, respectively). Overall, 343 (76.2%) patients received treatment for HM, which was delayed for longer than one month since diagnosis in 57 (16.6%). An overall response rate was observed in 140 (40.8%) patients after the first line of treatment. After a median follow-up of 35 days, overall mortality was 177/450 (39.3%) ; 30-day mortality was significantly higher in patients not receiving HM treatment (42.1%) than in those receiving treatment (27.4%, p = 0.004), either before and/or after COVID-19, or compared to patients receiving HM treatment at least after COVID- 19 (15.2%, p < 0.001). Age, severe/critical COVID-19, ≥2 comorbidities, and lack of HM treatment were independent risk factors for mortality, whereas a lymphocyte count >500/mcl at COVID-19 onset was protective. Conclusions: HM treatment should be delivered as soon as possible for patients with simultaneous diagnosis of COVID-19 and HM requiring immediate therapy.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus